Jeffrey Khong, Rachana Suresh, Kitae E Park, Hooman Soltanian
{"title":"新的轮廓，不同的风险：既往减肥手术与使用胰高血糖素样肽1受体激动剂进行美容手术患者的9年趋势和术后并发症的比较","authors":"Jeffrey Khong, Rachana Suresh, Kitae E Park, Hooman Soltanian","doi":"10.1093/asj/sjaf131","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The significant weight loss associated with bariatric surgery and glucagon-like peptide 1 receptor agonist (GLP-1 RA) use often prompts patients to seek aesthetic procedures to address changes in skin tightness and body contours.</p><p><strong>Objectives: </strong>We sought to examine trends in aesthetic surgery utilization and postoperative complication rates between these two patient populations.</p><p><strong>Methods: </strong>Using the TriNetX database, we identified patients undergoing aesthetic procedures between 2016-2024 and stratified cohorts based on prior bariatric surgery or GLP-1 RA use. Mean annual growth rates between groups were compared using least-squares means with post-hoc Tukey tests. Postoperative 90-day complication rates including hematoma, seroma, infection, wound dehiscence, DVT/PE, emergency department utilization, readmissions, and mortality were evaluated using risk ratios after propensity score matching.</p><p><strong>Results: </strong>Between 2016-2021, the mean annual growth rate aesthetic procedures among GLP-1 RA users was 36.1% per year, compared to 27.1% among post-bariatric patients (p=0.0026). After 2021, the mean annual growth rate aesthetic procedures increased to 53.8% (+17.7%, 95% CI: [10.4%, 25.4%]) for GLP-1 RA users and declined to -4% (-31.1%, 95% CI: [-37.7%, -25.5%]) for post-bariatric surgery patients. After matching, bariatric surgery patients had higher risk of hematoma (RR: 1.99; CI: [1.10, 3.62], p<0.05), infections (RR: 1.37; CI: [1.01, 1.88], p<0.05), and emergency department use (RR: 1.54; CI: [1.05, 2.26], p<0.05).</p><p><strong>Conclusions: </strong>Aesthetic surgery utilization is sharply increasing among patients with prior GLP-1 RA use compared to post-bariatric surgery patients. Postsurgical hematoma, infection, and emergency department utilization were greater in post-bariatric patients. Future studies are needed to investigate underlying factors.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New Contours, Different Risks: A 9-Year Comparison of Trends and Postoperative Complications in Patients Undergoing Aesthetic Surgery With Prior Bariatric Surgery vs Glucagon-Like Peptide 1 Receptor Agonist Use.\",\"authors\":\"Jeffrey Khong, Rachana Suresh, Kitae E Park, Hooman Soltanian\",\"doi\":\"10.1093/asj/sjaf131\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The significant weight loss associated with bariatric surgery and glucagon-like peptide 1 receptor agonist (GLP-1 RA) use often prompts patients to seek aesthetic procedures to address changes in skin tightness and body contours.</p><p><strong>Objectives: </strong>We sought to examine trends in aesthetic surgery utilization and postoperative complication rates between these two patient populations.</p><p><strong>Methods: </strong>Using the TriNetX database, we identified patients undergoing aesthetic procedures between 2016-2024 and stratified cohorts based on prior bariatric surgery or GLP-1 RA use. Mean annual growth rates between groups were compared using least-squares means with post-hoc Tukey tests. Postoperative 90-day complication rates including hematoma, seroma, infection, wound dehiscence, DVT/PE, emergency department utilization, readmissions, and mortality were evaluated using risk ratios after propensity score matching.</p><p><strong>Results: </strong>Between 2016-2021, the mean annual growth rate aesthetic procedures among GLP-1 RA users was 36.1% per year, compared to 27.1% among post-bariatric patients (p=0.0026). After 2021, the mean annual growth rate aesthetic procedures increased to 53.8% (+17.7%, 95% CI: [10.4%, 25.4%]) for GLP-1 RA users and declined to -4% (-31.1%, 95% CI: [-37.7%, -25.5%]) for post-bariatric surgery patients. After matching, bariatric surgery patients had higher risk of hematoma (RR: 1.99; CI: [1.10, 3.62], p<0.05), infections (RR: 1.37; CI: [1.01, 1.88], p<0.05), and emergency department use (RR: 1.54; CI: [1.05, 2.26], p<0.05).</p><p><strong>Conclusions: </strong>Aesthetic surgery utilization is sharply increasing among patients with prior GLP-1 RA use compared to post-bariatric surgery patients. Postsurgical hematoma, infection, and emergency department utilization were greater in post-bariatric patients. Future studies are needed to investigate underlying factors.</p>\",\"PeriodicalId\":7728,\"journal\":{\"name\":\"Aesthetic Surgery Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Aesthetic Surgery Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/asj/sjaf131\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aesthetic Surgery Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/asj/sjaf131","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
New Contours, Different Risks: A 9-Year Comparison of Trends and Postoperative Complications in Patients Undergoing Aesthetic Surgery With Prior Bariatric Surgery vs Glucagon-Like Peptide 1 Receptor Agonist Use.
Background: The significant weight loss associated with bariatric surgery and glucagon-like peptide 1 receptor agonist (GLP-1 RA) use often prompts patients to seek aesthetic procedures to address changes in skin tightness and body contours.
Objectives: We sought to examine trends in aesthetic surgery utilization and postoperative complication rates between these two patient populations.
Methods: Using the TriNetX database, we identified patients undergoing aesthetic procedures between 2016-2024 and stratified cohorts based on prior bariatric surgery or GLP-1 RA use. Mean annual growth rates between groups were compared using least-squares means with post-hoc Tukey tests. Postoperative 90-day complication rates including hematoma, seroma, infection, wound dehiscence, DVT/PE, emergency department utilization, readmissions, and mortality were evaluated using risk ratios after propensity score matching.
Results: Between 2016-2021, the mean annual growth rate aesthetic procedures among GLP-1 RA users was 36.1% per year, compared to 27.1% among post-bariatric patients (p=0.0026). After 2021, the mean annual growth rate aesthetic procedures increased to 53.8% (+17.7%, 95% CI: [10.4%, 25.4%]) for GLP-1 RA users and declined to -4% (-31.1%, 95% CI: [-37.7%, -25.5%]) for post-bariatric surgery patients. After matching, bariatric surgery patients had higher risk of hematoma (RR: 1.99; CI: [1.10, 3.62], p<0.05), infections (RR: 1.37; CI: [1.01, 1.88], p<0.05), and emergency department use (RR: 1.54; CI: [1.05, 2.26], p<0.05).
Conclusions: Aesthetic surgery utilization is sharply increasing among patients with prior GLP-1 RA use compared to post-bariatric surgery patients. Postsurgical hematoma, infection, and emergency department utilization were greater in post-bariatric patients. Future studies are needed to investigate underlying factors.
期刊介绍：
Aesthetic Surgery Journal is a peer-reviewed international journal focusing on scientific developments and clinical techniques in aesthetic surgery. The official publication of The Aesthetic Society, ASJ is also the official English-language journal of many major international societies of plastic, aesthetic and reconstructive surgery representing South America, Central America, Europe, Asia, and the Middle East. It is also the official journal of the British Association of Aesthetic Plastic Surgeons, the Canadian Society for Aesthetic Plastic Surgery and The Rhinoplasty Society.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
